-transparent.png){kind=logo}
Partially-purified preparations of transcription factor TFIIIC derived from either cytoplasmic (S100) or nuclear (NE) HeLa cell extracts possessed comparable activities when assayed by in vitro transcription, although it was possible to detect sequence-specific binding to the VAI RNA gene promoter by DNase I footprinting only with TFIIIC (NE). On the basis of mixing experiments, this difference could not be ascribed to either transcriptional or DNA-binding inhibitors. These findings provide further evidence for the existence of two forms of TFIIIC: one which is present in both extracts and is transcriptionally active; another which predominates in nuclear extracts and is transcriptionally inactive.
M W Van Dyke, and
R G Roeder
June 1987,
Proceedings of the National Academy of Sciences of the United States of America,
M W Van Dyke, and
R G Roeder
August 1991,
The EMBO journal,
M W Van Dyke, and
R G Roeder
May 1984,
Proceedings of the National Academy of Sciences of the United States of America,
M W Van Dyke, and
R G Roeder
September 1988,
The Journal of biological chemistry,
M W Van Dyke, and
R G Roeder
July 1981,
Proceedings of the National Academy of Sciences of the United States of America,
M W Van Dyke, and
R G Roeder
June 2013,
Cold Spring Harbor protocols,
M W Van Dyke, and
R G Roeder
June 2006,
Cell,
M W Van Dyke, and
R G Roeder
August 2001,
Nucleic acids research,
M W Van Dyke, and
R G Roeder
July 2016,
Cold Spring Harbor protocols,
M W Van Dyke, and
R G Roeder
October 1990,
Molecular and cellular biology,
